1
|
Cybulska-Stopa B, Czarnecka A, Ostaszewski K, Piejko K, Ziętek M, Dziura R, Galus L, Ziolkowska B, Seredynska J, Kamycka A, Bal W, Kubiatowski T, Switaj T, Kempa-Kaminska N, Rutkowska E, Rogala P, Kamińska-Winciorek G, Suwinski R, Mackiewicz J, Rutkowski P. 835P Efficacy of checkpoint inhibitors and targeted therapy depending on the line of treatment in patients with advanced / metastatic melanoma. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.961] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
2
|
Lewis K, Robert C, Ramella Munhoz R, Liszkay G, de la Cruz Merino L, Olah J, Queirolo P, Mackiewicz J, Li H, Zhu Q, Hertig C, Paranthaman N, McKenna E, Gutzmer R, McArthur G, Ascierto P. 813P Time to development of central nervous system (CNS) metastases (mets) with atezolizumab (A) or placebo (P) combined with vemurafenib (V) + cobimetinib (C): Updated results from the phase III IMspire150 study. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.939] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
3
|
Słowińska M, Dudzisz – Śledź M, Sobczuk P, Łasińska I, Pieruszka A, Cybulska – Stopa B, Kowalczyk A, Świtaj T, Czarnecka I, Koseła‐Paterczyk H, Rogala P, Paluchowska E, Składowski K, Mackiewicz J, Rutkowski P, Owczarek W. Analysis of efficacy and safety of vismodegib therapy in patients with advanced basal cell carcinoma ‐ real world multicenter cohort study. J Eur Acad Dermatol Venereol 2022; 36:1219-1228. [PMID: 35279879 PMCID: PMC9541446 DOI: 10.1111/jdv.18070] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2021] [Accepted: 02/09/2022] [Indexed: 11/30/2022]
Affiliation(s)
- M. Słowińska
- Department of Dermatology Military Institute of Medicine Warsaw Poland
| | - M. Dudzisz – Śledź
- Department of Soft Tissue/Bone Sarcoma and Melanoma Maria Skłodowska‐Curie National Research Institute of Oncology Warsaw Poland
| | - P. Sobczuk
- Department of Soft Tissue/Bone Sarcoma and Melanoma Maria Skłodowska‐Curie National Research Institute of Oncology Warsaw Poland
- Department of Experimental and Clinical Physiology Laboratory of Centre for Preclinical Research Medical University of Warsaw Warsaw Poland
| | - I. Łasińska
- Department of Medical and Experimental Oncology Heliodor Święcicki Clinical Hospital Poznań University of Medical Sciences Poznań Poland
- Department of Nursing Faculty of Medicine and Health Sciences Collegium Medicum University of Zielona Góra Zielona Góra Poland
| | - A. Pieruszka
- 1st Radiation and Clinical Oncology Department Maria Skłodowska‐Curie National Research Institute of Oncology Gliwice Branch Gliwice Poland
| | - B. Cybulska – Stopa
- Clinical Oncology Department Maria Skłodowska‐Curie National Research Institute of Oncology Cracow Branch Cracow Poland
| | - A. Kowalczyk
- Department of Oncology and Radiotherapy Medical University of Gdańsk Gdańsk Poland
| | - T. Świtaj
- Department of Soft Tissue/Bone Sarcoma and Melanoma Maria Skłodowska‐Curie National Research Institute of Oncology Warsaw Poland
| | - I. Czarnecka
- Department of Dermatology Military Institute of Medicine Warsaw Poland
| | - H Koseła‐Paterczyk
- Department of Soft Tissue/Bone Sarcoma and Melanoma Maria Skłodowska‐Curie National Research Institute of Oncology Warsaw Poland
| | - P. Rogala
- Department of Soft Tissue/Bone Sarcoma and Melanoma Maria Skłodowska‐Curie National Research Institute of Oncology Warsaw Poland
| | - E. Paluchowska
- Department of Dermatology Military Institute of Medicine Warsaw Poland
| | - K. Składowski
- 1st Radiation and Clinical Oncology Department Maria Skłodowska‐Curie National Research Institute of Oncology Gliwice Branch Gliwice Poland
| | - J. Mackiewicz
- Department of Medical and Experimental Oncology Heliodor Święcicki Clinical Hospital Poznań University of Medical Sciences Poznań Poland
- Department of Diagnostics and Cancer Immunology Greater Poland Cancer Centre Poznań Poland
| | - P. Rutkowski
- Department of Soft Tissue/Bone Sarcoma and Melanoma Maria Skłodowska‐Curie National Research Institute of Oncology Warsaw Poland
| | - W. Owczarek
- Department of Dermatology Military Institute of Medicine Warsaw Poland
| |
Collapse
|
4
|
Luke J, Rutkowski P, Queirolo P, Del Vecchio M, Mackiewicz J, Chiarion Sileni V, de la Cruz Merino L, Khattak M, Schadendorf D, Long G, Ascierto P, Mandala M, De Galitiis F, Sondak V, Scolyer R, Kirkwood J, Chen K, Ibrahim N, Ahsan S, Eggermont A. LBA3 Pembrolizumab versus placebo after complete resection of high-risk stage II melanoma: Efficacy and safety results from the KEYNOTE-716 double-blind phase III trial. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.2116] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
5
|
Gogas H, Dréno B, Larkin J, Demidov L, Stroyakovskiy D, Eroglu Z, Francesco Ferrucci P, Pigozzo J, Rutkowski P, Mackiewicz J, Rooney I, Voulgari A, Troutman S, Pitcher B, Guo Y, Yan Y, Castro M, Mulla S, Flaherty K, Arance A. Cobimetinib plus atezolizumab in BRAF V600 wild-type melanoma: primary results from the randomized phase III IMspire170 study. Ann Oncol 2020; 32:384-394. [PMID: 33309774 DOI: 10.1016/j.annonc.2020.12.004] [Citation(s) in RCA: 67] [Impact Index Per Article: 16.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2020] [Revised: 12/01/2020] [Accepted: 12/02/2020] [Indexed: 11/28/2022] Open
Abstract
BACKGROUND Emerging data suggest that the combination of MEK inhibitors and immunotherapeutic agents may result in improved efficacy in melanoma. We evaluated whether combining MEK inhibition and immune checkpoint inhibition was more efficacious than immune checkpoint inhibition alone in patients with previously untreated BRAFV600 wild-type advanced melanoma. PATIENTS AND METHODS IMspire170 was an international, randomized, open-label, phase III study. Patients were randomized 1 : 1 to receive cobimetinib (60 mg, days 1-21) plus anti-programmed death-ligand 1 atezolizumab (840 mg every 2 weeks) in 28-day cycles or anti-programmed death-1 pembrolizumab (200 mg every 3 weeks) alone until loss of clinical benefit, unacceptable toxicity, or consent withdrawal. The primary outcome was progression-free survival (PFS), assessed by an independent review committee in the intention-to-treat population. RESULTS Between 11 December 2017, and 29 January 2019, 446 patients were randomized to receive cobimetinib plus atezolizumab (n = 222) or pembrolizumab (n = 224). Median follow-up was 7.1 months [interquartile range (IQR) 4.8-9.9] for cobimetinib plus atezolizumab and 7.2 months (IQR 4.9-10.1) for pembrolizumab. Median PFS was 5.5 months [95% confidence interval (CI) 3.8-7.2] with cobimetinib plus atezolizumab versus 5.7 months (95% CI 3.7-9.6) with pembrolizumab [stratified hazard ratio 1.15 (95% CI 0.88-1.50); P = 0.30]. Hazard ratios for PFS were consistent across prespecified subgroups. In exploratory biomarker analyses, higher tumor mutational burden was associated with improved clinical outcomes in both treatment arms. The most common grade 3-5 adverse events (AEs) were increased blood creatine phosphokinase (10.0% with cobimetinib plus atezolizumab versus 0.9% with pembrolizumab), diarrhea (7.7% versus 1.9%), rash (6.8% versus 0.9%), hypertension (6.4% versus 3.7%), and dermatitis acneiform (5.0% versus 0). Serious AEs occurred in 44.1% of patients with cobimetinib plus atezolizumab and 20.8% with pembrolizumab. CONCLUSION Cobimetinib plus atezolizumab did not improve PFS compared with pembrolizumab monotherapy in patients with BRAFV600 wild-type advanced melanoma.
Collapse
Affiliation(s)
- H Gogas
- First Department of Medicine, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
| | - B Dréno
- Dermatology Department, CHU Nantes, CIC 1413, CRCINA, University Nantes, Nantes, France
| | - J Larkin
- Royal Marsden NHS Foundation Trust, London, United Kingdom
| | - L Demidov
- N.N. Blokhin Russian Cancer Research Center, Ministry of Health, Moscow, Russia
| | - D Stroyakovskiy
- Moscow City Oncology Hospital #62 of Moscow Healthcare Department, Moscow Oblast, Russia
| | - Z Eroglu
- Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, USA
| | | | - J Pigozzo
- Veneto Institute of Oncology IOV - IRCCS, Padua, Italy
| | - P Rutkowski
- Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
| | - J Mackiewicz
- Department of Medical and Experimental Oncology, Poznan University of Medical Sciences, and Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Center, Poznan, Poland
| | - I Rooney
- Genentech, Inc., South San Francisco, USA
| | - A Voulgari
- Roche Products Ltd, Welwyn Garden City, UK
| | - S Troutman
- Genentech, Inc., South San Francisco, USA
| | - B Pitcher
- Hoffmann-La Roche Ltd., Mississauga, Canada
| | - Y Guo
- Genentech, Inc., South San Francisco, USA
| | - Y Yan
- Genentech, Inc., South San Francisco, USA
| | - M Castro
- Genentech, Inc., South San Francisco, USA
| | - S Mulla
- Hoffmann-La Roche Ltd., Mississauga, Canada
| | - K Flaherty
- Massachusetts General Hospital Cancer Center, Boston, USA
| | - A Arance
- Department of Medical Oncology and IDIBAPS, Hospital Clínic Barcelona, Barcelona, Spain
| |
Collapse
|
6
|
Lewis K, Robert C, Ascierto P, Munhoz R, Liszkay G, Merino LDLC, Olah J, Queirolo P, Mackiewicz J, Li H, Zhu Q, McKenna E, McNally V, Gutzmer R, McArthur G. 1137P Incidence and time course of adverse events (AEs) with atezolizumab (A) in combination with vemurafenib (V) and cobimetinib (C) in the phase III IMspire150 study. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.1260] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
7
|
Cybulska-Stopa B, Regulski K, Wiśniowski R, Rajczykowski M, Suwinski R, Domagała-Haduch M, Piejko K, Drosik A, Bar-Letkiewicz I, Rauch L, Szczęsny T, Ziobro M, Mackiewicz J. Obese and overweight is associated with better prognosis in metastatic colorectal cancer patients treated with bevacizumab. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz246.128] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
8
|
Danieluk K, Święch- Zubilewicz A, Osęka M, Mackiewicz J. Biological model of Zebrafish- a new research trend in ophthalmology, for an antiangiogenic treatment. Acta Ophthalmol 2017. [DOI: 10.1111/j.1755-3768.2017.01561] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- K. Danieluk
- Department of Retina and Vitreous Humour Surgery; Medical University of Lublin; Lublin Poland
- Centre of Experimental Medicine; Medical University of Lublin; Lublin Poland
| | - A. Święch- Zubilewicz
- Department of Retina and Vitreous Humour Surgery; Medical University of Lublin; Lublin Poland
| | | | - J. Mackiewicz
- Department of Retina and Vitreous Humour Surgery; Medical University of Lublin; Lublin Poland
| |
Collapse
|
9
|
Mackiewicz J. [Inky marks of memory]. Med Nowozytna 2003; 8:223-32. [PMID: 12569945] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/28/2023]
Abstract
An exhibition in the Special Collections Department of the Main Medical Library in Warsaw, the second in a series devoted to women's themes, presenting the correspondence of Polish women-doctors, the wives and fiansées of well-known physicians and the patients of the latter, complemented with photographic documentation.
Collapse
|
10
|
lżycki D, Osawa T, Ozer K, Ozmen S, Mackiewicz J, Siemionow M. 217. Thymic dependence of tolerance in vascularized composite tissue allografts under Cyclosporine A and ab-T Cell Receptor monoclonal antibody protocol. Rep Pract Oncol Radiother 2003. [DOI: 10.1016/s1507-1367(03)70701-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
11
|
Mackiewicz J, Krupski W, Haszcz D, Zagórski Z. [Localization of intraocular foreign bodies using computed tomography]. Klin Oczna 2002; 103:21-3. [PMID: 11605580] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/21/2023]
Abstract
PURPOSE To present the evaluation of computed tomography (CT) application for detecting the intraocular foreign bodies. MATERIAL AND METHODS Sixteen computed tomographies of orbit to localise a foreign body were performed in the 2nd Radiology Department at Lublin University School of Medicine from May 1995 to October 1998. During examination 2 mm computed tomography cuts were taken. In almost all cases fundus examination was not possible because of hazy media (cataract, vitreous haemorrhage, endophthalmitis). Pars plana vitrectomy was applied to remove foreign body in all cases. RESULTS In 14 cases a foreign body was localised inside the eye (3 of them were embedded in the wall of the eye) and in 2 cases a double perforation was noticed. With pars plana vitrectomy 12 of 14 intraocular foreign bodies were removed. Two foreign bodies deeply embedded in the wall of the eye were left. One of the two foreign bodies after double perforation was removed from the orbit and the second, which was localized deeply in the orbit, was left. CONCLUSION The localisation of the foreign bodies using the computed tomography is a very accurate and sensitive method, facilitating further surgery.
Collapse
|
12
|
Mackiewicz J, Zagórski Z. [Vitrectomy in the treatment of endophthalmitis]. Klin Oczna 2002; 103:17-20. [PMID: 11605579] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/21/2023]
Abstract
PURPOSE To present our experience with the surgical management of endophthalmitis. MATERIAL AND METHODS The results of 27 pars plana vitrectomies in 19 patients with clinical evidence of endophthalmitis were analysed. The endophthalmitis was considered as endogenous in 4 cases and exogenous in 15 cases. RESULTS With the use of vitrectomy good anatomical and functional results were obtained. Pre-operative visual acuity was worse than 1/50 in 16 patients and ranged from 1/50 to 4/50 in 3 patients. Postoperative visual acuity was worse than 1/50 in 7 patients, ranged from 1/50 to 4/50 in 3 patients and was better than 5/50 in 9 patients. CONCLUSIONS Pars plana vitrectomy in the management of endophthalmitis makes it possible to collect material for culture, removal of viable organisms and inflammatory products. In cases of posttraumatic endophthalmitis vitrectomy allows to prevent future complications.
Collapse
Affiliation(s)
- J Mackiewicz
- I Klinika Okulistyki AM ul. Chmielna 1 20-079 Lublin
| | | |
Collapse
|
13
|
Sznitowska M, Janicki S, Zurowska-Pryczkowska K, Mackiewicz J. In vivo evaluation of submicron emulsions with pilocarpine: the effect of pH and chemical form of the drug. J Microencapsul 2001; 18:173-81. [PMID: 11253934 DOI: 10.1080/02652040010000442] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
Submicron emulsions containing 2.0% w/v pilocarpine as pilocarpine HCl, soybean oil (10% w/v) and egg lecithin (1.2% w/v) were formulated. Emulsions at pH 5.0, 6.5 and 8.5 were applied to the rabbit's eye, and the reduction in pupil diameter was measured for 6 h. The miotic effect was compared with that obtained with aqueous solutions at the same pH. A prolonged miotic effect was observed when the submicron emulsion was used as a vehicle. After application of emulsions at pH 5.0, 6.5 or 8.5, the time when 20% reduction of pupil diameter was still observed was 3.9 +/- 1.1 h, 4.3 +/- 1.3 h and 5.3 +/- 0.8 h, respectively, while, after application of a solution, this parameter was shorter by 30-40%. AUC(0-6h) values were larger after application of the submicron emulsions in comparison to aqueous solutions; however, statistically significant differences were only observed for emulsions at pH 6.5. Although the bioavailability of the drug is pH dependent, emulsions at higher pH cannot be considered for clinical use because of pilocarpine degradation which occurs with a similar rate as in aqueous solutions. Introduction of pilocarpine into the oily phase in the form of pilocarpine base or its oleate did not improve either the physicochemical or the pharmacological properties of the formulations. Irrespective of the pH and chemical form of pilocarpine used for emulsion preparation, practically all drug was found in the aqueous phase of the emulsion; thus, partitioning to the oily phase was negligible.
Collapse
Affiliation(s)
- M Sznitowska
- Department of Pharmaceutical Technology, Medical University of Gdansk, Poland.
| | | | | | | |
Collapse
|
14
|
Biziorek B, Mackiewicz J, Zagórski Z, Krwawicz L, Haszcz D. Etiology of uveitis in rural and urban areas of mid-eastern Poland. Ann Agric Environ Med 2001; 8:241-243. [PMID: 11748883] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
The aim of this study was to assess and compare the frequencies of uveitis etiology in inhabitants of rural and urban areas of mid-eastern Poland. We reviewed the cases of 563 patients (263 males, 300 females; aged 2-87) with uveitis, treated at the 1st Department of Ophthalmology at the Medical Academy in Lublin and at the District Ophthalmic Hospital in Kielce, Poland, from January 1996-December 2000. Anatomical classification of uveitis was used according to the International Uveitis Study Group and etiological classification including uveitis associated with trauma, infection, systemic disease, non-associated with a systemic disease and masquerade syndromes. Data regarding age, gender, place of residence, anatomical location and etiology of uveitis were obtained. Statistical analyses were performed using Pearson's chi-square test, Spearman's rank correlation test and logistic regression. Etiology of uveitis was established in 70.0% of cases. The most common cause of uveitis was infection. Patients from rural areas were significantly more likely to have uveitis of infectious origin whereas patients from urban areas significantly more likely to have uveitis associated with a systemic disease. In conclusion, the pattern of uveitis in mid-eastern Poland confirms the influence of environmental factors on the etiology of this heterogenous disease.
Collapse
Affiliation(s)
- B Biziorek
- 1st Department of Ophthalmology, Medical Academy, Lublin, Poland.
| | | | | | | | | |
Collapse
|
15
|
Kawa P, Mackiewicz J, Zagórski Z, Szajner M. [Secondary glaucoma in the course of arterio-cavernous fistula: a case report]. Klin Oczna 1999; 101:217-20. [PMID: 10526449] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/14/2023]
Abstract
PURPOSE To present a case of 59-year-old woman with the symptoms of redness, proptosis of her left eye and temporary bruit in her head. METHODS Basic ophthalmological examination, measurement of proptosis, tonometry, visual field examination (Humphrey 30-2 threshold) CT, MRI and carotid angiography were performed. CLINICAL SIGNS Proptosis of the left eye, dilatation of the episcleral vessels, fundus examination--optic disc normal, enlarged and engorged venous vessels, intraretinal haemorrhages in posterior pole. Tonometry--13 mm Hg--right eye, 24 mm Hg--left eye. Perimetry--general reduction of sensitivity. CT scan--abnormal structure (0.9 x 0.4 cm) in the medial part of the left orbit, without enhancement after applying contrast. MRI examination--enlargement of extraocular muscles of the left eye. Carotid artery angiography revealed indirect carotid--cavernous fistula. CONCLUSION Special investigations like CT and MRI showed different picture, final diagnosis could be based upon the clinical picture and confirmed by angiography.
Collapse
Affiliation(s)
- P Kawa
- I Kliniki Okulistyki AM w Lublinie
| | | | | | | |
Collapse
|
16
|
Mańkowska A, Zagórski Z, Kawa P, Mackiewicz J. [Diode laser trans-scleral cyclo-photo-coagulation]. Klin Oczna 1999; 101:103-4. [PMID: 10418232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/13/2023]
Abstract
The purpose of this study is to present the results of treatment of refractory glaucoma with diode laser transscleral cyclophotocoagulation (DLCT). 88 patients (from 10 to 91 years old) were treated with diode laser. The follow up was 6 months. Mean intraocular pressure (IOP) before treatment was 38.2 mm Hg, 1 week after treatment--23.8 mm Hg, 1 month after treatment--21.3 mm Hg, after 6 months--19.0 mm Hg. We repeated treatment in 5 patients (5.6%). In 2 patients we observed hypotony--about 2 mm Hg. Diode laser cycloablation is a relatively safe and effective method in treatment of advanced refractory glaucoma.
Collapse
|
17
|
Mackiewicz J. [First women with physician's diploma on the Russian and Austrian occupation areas]. Med Nowozytna 1999; 6:79-98. [PMID: 14631979] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/27/2023]
Abstract
The first Polish women physicians started their work in Warsaw by the end of the 19th century. In view of the fact that no women were admitted to universities on the area of both occupying countries, they were graduates of Swiss universities. They often waited for the official recognition of their diplomas in the Russian colleges for a few years. In 1900 on the Polish area under the Austrian occupation women were given an access to the medical faculties at the Universities of Cracow and Lvov. Still, at that time the majority of doctors completed their studies abroad. Until the World War I the number of professionally active women physicians ranged from a few to a dozen in Warsaw, Cracow and Lvov. They had speciality mainly in gynecology and obstetrics as well as pediatrics. They frequently came from urban intelligentsia without much wealth, and were commonly the descendants of land owners. Nearly all of the women physicians at that time dealt with social work and participated in intellectual life of their cities.
Collapse
|
18
|
Kawa P, Mańkowska A, Mackiewicz J, Zagórski Z. [Solar retinopathy]. Klin Oczna 1998; 100:235-7. [PMID: 9770984] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/09/2023]
Abstract
The purpose of this study is the present clinical evaluation of 21 patients (number of affected eyes--33), who watched eclipse of the sun on 12 October 1996. All patients had general ophthalmic examination with emphasis on visual acuity, visual field, Amsler test, fluorescein angiography and fundus appearance. Eleven out of 21 patients had at least one follow up examination (number of affected eyes--17). None of the patient received any treatment. All patients revealed tiny, central scotomata--positive Amsler test and decreased visual acuity on the first visit; reading Snellen chart could be improved in all patients by adequate head tilt or eye movement (improvement up to 3 Snellen chart lines). No signs of retinopathy were observed in two eyes with uncorrected refractive error and one amblyopic eye. After 7-8 weeks the visual acuity was decreased to 5/30 in two eyes and to 5/10 in ten eyes. In all those eyes persisted a tiny, central scotoma. Looking at the eclipse of the sun in spite of using primitive eye protection may cause irreversible retinal damage. Return of visual acuity to 5/5 does not always imply complete recovery because of persistent central scotoma.
Collapse
Affiliation(s)
- P Kawa
- Katedry i I Kliniki Okulistyki AM w Lublinie
| | | | | | | |
Collapse
|
19
|
Mackiewicz J, Szczesny P, Zagórski Z. [Histopathologic studies of the rabbit retina after use of perfluorodecalin]. Klin Oczna 1998; 100:5-8. [PMID: 9685790] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
PURPOSE To investigate the retinal toxicity of a vitreous substitute perfluorodecalin (PFD) in the rabbit eye up to 2 weeks after injection. MATERIAL AND METHODS A space was created in the vitreous cavity by injecting 0.4 cc of perfluoropropane gas. After 3 days gas-fluid exchange was performed. Experimental eyes were injected with 1 cc of PFD and control eyes with 1 cc of Ringer solution. The eyes were enucleated 1, 3, 6 and 14 days after the procedure and histological studies were conducted. RESULTS Control samples showed almost normal histology. One day after PFD injection photoreceptor nuclei dropout and migration below the outer limiting membrane, pyknosis and occasional densification of cell bodies were observed. After 3 days glial cell hypertrophy and accumulation of macrophages above the inner limiting membrane was also noted. After 6 days necrosis was observed in the outer and inner retinal layers. Foci of cell death in the retina were also observed 14 days after PFD injection. CONCLUSION PFD induced degenerative changes in the rabbit retina within the first 24 hours after administration. Structural alterations in the inner and outer retina persisted within the two weeks of observation. Our results support the removal of PFD at the end of the primary surgical procedure.
Collapse
|
20
|
Mackiewicz J, Mańkowska A, Kawa P, Zagórski Z. [Intraretinal foreign bodies]. Klin Oczna 1998; 99:393-5. [PMID: 9685787] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
PURPOSE To present our experience with the removal of intraretinal foreign bodies. MATERIAL AND METHODS 9 intraretinal foreign bodies were removed by pars plana vitrectomy. Laser photocoagulation of the retina surrounding the foreign body was performed either before surgery or intraoperatively (endolaser). Pars plana vitrectomy with foreign body removal through the sclerotomy site with endomagnet and/or forceps was performed. In some cases fluid-gas exchange was done. RESULTS The average follow-up period was 6.2 months. Seven of nine foreign bodies were magnetic and two were nonmagnetic. Five of seven magnetic foreign bodies had negative magnetic traction as the first surgical procedure. In these 9 eyes, final visual acuity was below 1/50 in 2 eyes and over 5/50 in 7 eyes. CONCLUSION Pars plana vitrectomy should be the method of choice in removal of intraretinal foreign bodies.
Collapse
|
21
|
Mackiewicz J, Stransky TJ. [Retinitis due to cytomegalovirus in AIDS]. Klin Oczna 1995; 97:74-76. [PMID: 7474799] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
Abstract
Clinical course of 4 AIDS patients suffering from CMV retinitis is presented. Two patients were treated with ganciclovir, one died before starting the treatment and one was vitrectomized with silicone oil injection. Of the two patients treated with ganciclovir one improved significantly when the other continued to deteriorate and died after 8 months of follow-up. Early diagnosis and treatment of patients with zone I involvement gives the best chances for improvement. Mean life expectancy in aids patients after diagnosis of CMV retinitis is 7-10 months.
Collapse
|
22
|
Mackiewicz J, Wendorff J. [Case of subacute myelo-optico-neuropathy]. Neurol Neurochir Pol 1980; 14:121-3. [PMID: 6445513] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
A 52-year-old female patient is reported in whom after taking of about 20 g Clioquinol blindness and paralysis of extremities with urinary incontinence developed. Complete cure ensued.
Collapse
|
23
|
Abstract
Plasma warfarin half-life was estimated in four patients with renal dysfunction and five normal control subjects. Hypoprothrombinemic responsiveness to a single oral dose of warfarin (0.75 mg/kg) was also evaluated for both groups. The mean warfarin half-life of 29.9+/-5.0 (S.E.M.) hours for renal patients was significantly shorter than the 44.8+/-6.0 hours half-life for normal controls (P less than 0.05). Additionally, a positive correlation was found between warfarin half-life and creatinine clearance. Pharmacologic responsiveness to warfarin was comparable for both groups. It therefore appears that patients with renal dysfunction do not possess an increased susceptibility, either pharmacokinetic or pharmacologic, to the hypoprothrombinemic effect of warfarin.
Collapse
|
24
|
Bachmann K, Shapiro R, Mackiewicz J. Influence of renal dysfunction on warfarin plasma protein binding. J Clin Pharmacol 1976; 16:468-72. [PMID: 977790] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
The in vitro plasma protein binding of warfarin was evaluated by ultrafiltration in plasma from seven normal subjects and seven patients with varying degrees of renal dysfunction. The unbound, or free, warfarin fraction was twice as high in the plasma samples withdrawn from patients with renal impairment than in the samples obtained from normal volunteers. Furthermore, there was a positive correlation between the extent of renal dysfunction and the magnitude of the free warfarin fraction when either creatinine clearance, plasma creatinine, or BUN was used to estimate renal function.
Collapse
|
25
|
Mackiewicz J, Split W. [Herman's syndrome (pyramido-extrapyramidal syndrome with livedo racemosa)]. Wiad Lek 1973; 26:645-8. [PMID: 4700962] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
26
|
Mackiewicz J, Orzechowska-Wolczykowa M, Swietliczko I. [Diagnostic difficulties in a case of bilateral exophthalmos with complete ophthalmoplegia and blindness]. Klin Oczna 1973; 43:173-6. [PMID: 4805038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
27
|
Mackiewicz J, Split W, Klimek A. [Case of Opalski's syndrome with bladder sphincter disorders]. Neurol Neurochir Pol 1973; 7:89-91. [PMID: 4690707] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
28
|
Mackiewicz J, Orzechowska-Wolczyk M, Poźniak-Patewicz E, Wendorff J. [Catamnestic studies in petit mal epilepsy]. Neurol Neurochir Pol 1972; 6:749-53. [PMID: 4629343] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
29
|
Jagodziński Z, Mackiewicz J, Papierz W. [Primary papilloma of the cerebellopontine angle with metastases to the cerebral hemisphere]. Neurol Neurochir Pol 1972; 6:149-56. [PMID: 4536983] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
30
|
Mackiewicz J, Hain-Mazurkiewicz G. [2 cases of idiopathic cranial polyneuritis]. Wiad Lek 1968; 21:1343-6. [PMID: 5697948] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
|
31
|
Mackiewicz J, Szaff-Mackiewicz J. [On the therapeutic managment of the so-called carpal tunnel syndrome]. Wiad Lek 1967; 20:1641-3. [PMID: 6066210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|
32
|
Mackiewicz J. [On the diagnosis and treatment of botulism]. Wiad Lek 1967; 20:489-92. [PMID: 6041767] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|
33
|
Mackiewicz J, Gershon S. An experimental study of the neuropathological effects of imipramine in animals of different ages. Int J Neuropsychiatry 1965; 1:608-15. [PMID: 5886539] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|